Podcasts & Videos

With demand growing for its natural beauty products, Alex Gluyas speaks with the CEO of BWX, Dave Fenlon, to discuss the company's goal of moving all manufacturing of its brands to Australia, its new manufacturing and distribution centre in Melbourne and how its Sukin brand is driving sales growth.

Evan and Tom explore different investment strategies and take your questions.

With human resources teams unable to physically connect with employees during COVID lockdowns, IntelliHR has seen demand for its staff management technology grow faster than ever. After recently attracting the attention of tech investor Bevan Slattery, Alex Gluyas speaks with IntelliHR CEO, Rob Bromage, who explains the opportunity COVID has provided: "For the last five years, we've been working really hard and paddling out for a big wave and along has come a tsunami."

Evan and Tom look at the most commonly asked about assets when it comes to investing.

Top financial adviser Sally Huynh joins James Kirby in this week's episode of The Money Café for a discussion on the key issues and investment trends emerging from COVID including gold's spectacular rally, early super withdrawals and the state of industry funds as airports and toll roads struggle.

Alex Gluyas speaks with the CEO of REA Group, Owen Wilson, about the year that has been in Australia's property market, from the Hayne Royal Commission's impact, the signs of recovery earlier this year and then the onset of COVID, and his thoughts on why the property market might escape in better condition than first thought.

This week on Talking Finance, Alex Gluyas is joined by Professor of Infectious Diseases at ANU's Medical School, Professor Peter Collignon, for a global discussion on all things COVID, including how safe Russia's rushed vaccine is, Sweden's herd immunity strategy and why Australia needs to learn how to live with the virus, while Portfolio Manager at Tribeca Investment Partners, Jun Bei Liu, gives her take on earnings season so far and what's driven the Nasdaq and S&P 500 to record highs. EY Oceania Chief Economist, Jo Masters, explains why Australia's economic fundamentals place it in better shape than most nations to get through the current downturn and Political Editor at The New Daily, Josh Butler, shares his thoughts on Victoria's hotel quarantine inquiry and China's latest curveball to Australia's wine industry.

Following its recent listing on the ASX, Alex Gluyas speaks with the founder and CEO of 4DMedical, Andreas Fouras, to discuss the company's lung imaging technology, its usefulness in detecting and managing acute respiratory distress syndrome (ARDS) in COVID patients and the process of commercialising in the US and beyond.

Alex Gluyas catches up with the CEO of Ava Risk Group, Rob Broomfield, to discuss his transition to being the group's CEO, how the company has navigated through COVID and its most recent quarterly update which saw its share price spike.

In this week's Q&A, Eureka Report's SMSF Coach and Prime Financial Group's Managing Director of SMSF, Olivia Long, answers a number of subscriber questions relating to self-managed super funds.

With the onset of COVID, Zoom's daily active participants soared from 10 million to 300 million. Alex Gluyas catches up with the video conferencing giant's head of Australia and Asia Pacific, Michael Chetner, to discuss how it was forced to pivot from focusing on its main enterprise market to keeping society connected, the privacy and security issues it's faced and where Zoom fits into life post-COVID.

Following its recent listing on the ASX, Alex Gluyas speaks with the CEO of Aroa Biosurgery, Brian Ward, to discuss the company's IPO, its medical products used for soft tissue regeneration, and the expansion of its commercial operations in the US and beyond.